PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

16 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Haunhorst, S.* et al.: Towards an understanding of physical activity-induced post-exertional malaise: Insights into microvascular alterations and immunometabolic interactions in post-COVID condition and myalgic encephalomyelitis/chronic fatigue syndrome. Infection, DOI: 10.1007/s15010-024-02386-8 (2024)
2.
Hopff, S.M.* et al.: Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP). Infection, DOI: 10.1007/s15010-024-02270-5 (2024)
3.
Maison, N. et al.: Old foes following news ways?—Pandemic-related changes in the epidemiology of viral respiratory tract infections. Infection 52, 209-218 (2024)
4.
Triebelhorn, J.* et al.: Clinical and immunological outcomes of SARS-CoV-2-infected vaccine responders, vaccine non-responders, and unvaccinated patients evaluated for neutralizing monoclonal antibody treatment at a single German tertiary care center: A retrospective cohort study with prospective follow-up. Infection, DOI: 10.1007/s15010-023-02171-z (2024)
5.
Wagner, L.* et al.: Evaluation of a host-protein signature score for differentiating between bacterial and viral infections: Real-life evidence from a German tertiary hospital. Infection, DOI: 10.1007/s15010-024-02384-w (2024)
6.
Zeller, I. et al.: Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic. Infection, DOI: 10.1007/s15010-024-02312-y (2024)
7.
Glueck, O.M.* et al.: Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation. Infection, DOI: 10.1007/s15010-023-02116-6 (2023)
8.
Shi, Y.* et al.: Persistent symptoms and risk factors predicting prolonged time to symptom-free after SARS‑CoV‑2 infection: An analysis of the baseline examination of the German COVIDOM/NAPKON-POP cohort. Infection 51, 1679-1694 (2023)
9.
Steinbeis, F.* et al.: Analysis of acute COVID-19 including chronic morbidity: Protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP). Infection:12 (2023)
10.
Horn, A.P.* et al.: Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: Design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection 49, 1277-1287 (2022)
11.
Maison, N. et al.: The rising of old foes: Impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections. Infection 50, 519-524 (2022)
12.
Jakob, C.E.M.* et al.: First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)". Infection 49, 63–73 (2021)
13.
Munker, D. et al.: Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection, DOI: 10.1007/s15010-021-01669-8 (2021)
14.
Würstle, S.* et al.: Self-sampling versus health care professional-guided swab collection for SARS-CoV-2 testing. Infection 49, 927-934 (2021)
15.
Koller, D.* et al.: Variation in antibiotic prescriptions: Is area deprivation an explanation? Analysis of 1.2 million children in Germany. Infection 41, 121-127 (2013)
16.
Kleinschmidt, A.M.* ; Matuschke, A.* ; Goebel -, F.D.* ; Erfle, V.F. & Hehlmann., R.*: Serological markers as prognostic criteria for the course of HIV infection. Infection 19, S89-S92 (1991)
▮◀ ◀◀ ▶▶ ▶▮